Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
Clinical trial NCT04299893 · RECRUITING
Trial details
- NCT number
- NCT04299893
- Sponsor
- Bernardino Clavo, MD, PhD
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2027-09-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.